|
Age, years
|
61 ± 12
|
61 ± 13
|
0.97
|
|
Gender
| | | |
|
Male, number (percentage)
|
24 (70)
|
88 (67)
|
0.70
|
|
Female, number (percentage)
|
10 (30)
|
43 (33)
|
0.70
|
|
Body mass index, kg/m2
|
28.5 ± 5
|
27.5 ± 4.2
|
0.20
|
|
Parsonnet score
|
13.6 ± 9.2
|
12.1 ± 6.8
|
0.35
|
|
Comorbidity
| | | |
|
Renal disease, number (percentage)
|
4 (11)
|
8 (6)
|
0.26
|
|
Diabetic status, number (percentage)
|
12 (35)
|
44 (34)
|
0.85
|
|
Angiotensin-converting enzyme inhibitors, number (percentage)
|
10 (29)
|
45 (34)
|
0.58
|
|
Cardiac intervention
| | | |
|
Coronary, number (percentage)
|
19 (56)
|
81 (62)
|
0.20
|
|
Valvular, number (percentage)
|
9 (26)
|
41 (31)
|
0.58
|
|
Both, number (percentage)
|
6 (17)
|
9 (7)
|
0.051
|
|
Reintervention, number (percentage)
|
2 (6)
|
6 (5)
|
0.75
|
|
Surgical data
| | | |
|
Total cardiopulmonary bypass time, minutes
|
101 ± 33
|
93 ± 33
|
0.20
|
|
Aortic clamping time, minutes
|
61.6 ± 27.3
|
54 ± 22.8
|
0.11
|
|
Tranexamic acid, number (percentage)
|
8 (26)
|
78 (60)
|
<0.01
|
|
No antifibrinolytics, number (percentage)
|
26 (76)
|
53 (40)
|
0.44
|
|
Intensive care unit stay, days
|
7.8 ± 6.4
|
3.2 ± 1.7
|
<0.01
|
|
Hospital stay, days
|
17.6 ± 20.5
|
9.1 ± 6.2
|
<0.01
|
